DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Drug development
Drug development
Clinical Pharmacology 1: Phase 1 Studies and Early Drug Development
Drugs and Drug Development: Making a Drug
Early-Phase Drug Discovery
Comparative Thermodynamics of Partial Agonist Binding to An
Research and Development in the Pharmaceutical Industry
A Molecular and Chemical Perspective in Defining Melatonin Receptor Subtype Selectivity
Of TB Drug Development: What's on the Horizon (For Patients with Or Without
Drug Development
N21-130S009 Linezolid Clinical BPCA
Clinical Pharmacology Considerations During Phase 2 and Phase 3 of Drug Development
Drug Discovery & Development
Molecular Mechanisms of Cereblon-Based Drugs
Drug Development Process
Immunomodulatory Drugs and Their Therapeutic Effect in Hematological Malignancies Through Cereblon
Targeting Mtor for Cancer Therapy Hui Hua1, Qingbin Kong2, Hongying Zhang2, Jiao Wang3, Ting Luo4 and Yangfu Jiang2*
Overview of Drug Development
Clinical Pharmacokinetic Studies of Pharmaceuticals
FDA Guidance for Industry Population Pharmacokinetics
Top View
Exploring New Frontiers for the Pharmacological Treatment of Insomnia
Pharmacokinetics in Drug Development
Pharmacokinetic/Pharmacodynamic Analysis of Tedizolid Phosphate Compared to Linezolid for the Treatment of Infections Caused by Gram-Positive Bacteria
Cpmp/Ewp/2655/99
Advanced Drug Development and Manufacturing
Rapamycin and Mtor: a Serendipitous Discovery and Implications for Breast Cancer Belinda Seto
Mtor Signaling in Cancer and Mtor Inhibitors in Solid Tumor Targeting Therapy
Pharmacology and Structural Analysis of Ligand Binding to the Orthosteric Site of Glutamate-Like Glud2 Receptors S
Pretomanid Prescribing Information
Pharmacology Skills for Drug Discovery
Mtor Signaling, Function, Novel Inhibitors, and Therapeutic Targets
Advances in Drug Development
How FDA Approves Drugs and Regulates Their Safety and Effectiveness
2019 Antibacterial Agents in Clinical Development
Melatonin Receptor Agonist Piper Betle L. Ameliorates Dexamethasone‑Induced Early Life Stress in Adult Zebrafish
Winning at Your Drug Development Strategy Download
The Benefits of Modeling and Simulation in Drug Development the Benefits of Modeling and Simulation in Drug Development
Biopharmaceutical Research & Development
Integrated Drug Discovery in Continuous Flow
'Lead' to 'Candidate' Optimisation Using Multi-Parametric Principles
The Price of Innovation: New Estimates of Drug Development Costs Joseph A
ISOA/ARF Drug Development Tutorial
Value-Driven Drug Development—Unlocking the Value of Your Pipeline
Use of Enrichment in Drug Development Trial Design
Medications Development: Drug Discovery, Databases, and Computer-Aided Drug Design
The Role of Regulatory Toxicology in Drug Development
The Model-Informed Drug Development Imperative in Oncology R&D White Paper
A Drug Development Overview of Pharmacokinetic Principles Related to ANDA/505(B)(2) Submissions
Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders
A Review on Applications of Computational Methods in Drug Screening and Design
Pushing the Envelope in the Mtor Pathway: the Second Generation of Inhibitors
Drug Development and Ethical Considerations
Marine-Derived Natural Products As ATP-Competitive Mtor Kinase Inhibitors for Cancer Therapeutics
Inhibition of the Checkpoint Protein PD-1 by the Therapeutic Antibody
HIV Protease Inhibitors for the Treatment of Multiple Myeloma
New Drug Development Process at One Time Or Another Everyone Has
A Case Study on the Decision- Making Behind the Development of Linezolid, Daptomycin, and Lysobactin
ANTIBACTERIAL AGENTS in CLINICAL DEVELOPMENT an Analysis of the Antibacterial Clinical Development Pipeline, Including Tuberculosis
Improving the Success of Lead Optimization with High-Quality Data and in Silico Tools
Drug Discovery and Drug Development
Drug Development & the FDA Goals & Objectives Outline an History Of
Creating a Comprehensive Drug Development Plan